The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1r,4r)-(4-((5-Chloro-4-(2-(((tetrahydro-2H-pyran-4-yl)methyl)amino)thiazol-4-yl)pyridin-2-yl)amino)cyclohexyl)cyclopropanecarboxamide ID: ALA4287306
PubChem CID: 145993367
Max Phase: Preclinical
Molecular Formula: C24H32ClN5O2S
Molecular Weight: 490.07
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4CCOCC4)n3)c(Cl)cn2)CC1)C1CC1
Standard InChI: InChI=1S/C24H32ClN5O2S/c25-20-13-26-22(28-17-3-5-18(6-4-17)29-23(31)16-1-2-16)11-19(20)21-14-33-24(30-21)27-12-15-7-9-32-10-8-15/h11,13-18H,1-10,12H2,(H,26,28)(H,27,30)(H,29,31)/t17-,18-
Standard InChI Key: DGELUECQJXKHPB-IYARVYRRSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
10.5775 -20.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2987 -19.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5396 -18.5695 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.0004 -19.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4966 -19.9094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8644 -19.6337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4740 -17.8265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7151 -18.5394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7497 -18.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0129 -20.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2414 -18.5394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7214 -19.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5763 -20.8769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0100 -20.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2979 -21.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2961 -19.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2987 -17.8265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7264 -21.2834 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.4740 -19.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8250 -19.2607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0659 -18.5394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8685 -18.8087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5873 -18.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5932 -17.5816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8826 -17.1617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1643 -17.5694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1566 -18.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8898 -16.3367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6078 -15.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6149 -15.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3186 -16.3491 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0310 -14.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2060 -14.3889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 4 2 0
10 14 1 0
13 15 1 0
9 12 2 0
8 17 1 0
1 6 1 0
11 21 1 0
17 7 1 0
15 10 2 0
21 19 1 0
14 16 2 0
4 20 1 0
19 2 1 0
1 13 2 0
20 11 1 0
16 1 1 0
21 7 1 0
2 8 1 0
4 3 1 0
10 18 1 0
14 12 1 0
3 9 1 0
12 5 1 0
22 6 1 6
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 1
28 29 1 0
29 30 1 0
29 31 2 0
32 30 1 0
33 32 1 0
30 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 490.07Molecular Weight (Monoisotopic): 489.1965AlogP: 4.95#Rotatable Bonds: 8Polar Surface Area: 88.17Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.79CX LogP: 3.60CX LogD: 3.60Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.61
References 1. Wang B, Wu J, Wu Y, Chen C, Zou F, Wang A, Wu H, Hu Z, Jiang Z, Liu Q, Wang W, Zhang Y, Liu F, Zhao M, Hu J, Huang T, Ge J, Wang L, Ren T, Wang Y, Liu J, Liu Q.. (2018) Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor., 158 [PMID:30253346 ] [10.1016/j.ejmech.2018.09.025 ]